WallStSmart

Cboe Global Markets Inc (CBOE)vsCME Group Inc (CME)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CME Group Inc generates 34% more annual revenue ($6.76B vs $5.06B). CME leads profitability with a 63.4% profit margin vs 26.7%. CBOE appears more attractively valued with a PEG of 2.64. CBOE earns a higher WallStSmart Score of 74/100 (B).

CBOE

Strong Buy

74

out of 100

Grade: B

Growth: 8.0Profit: 9.0Value: 4.3Quality: 7.5
Piotroski: 4/9Altman Z: 2.62

CME

Buy

55

out of 100

Grade: C-

Growth: 4.7Profit: 8.0Value: 4.3Quality: 4.5
Piotroski: 1/9Altman Z: -0.67

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CBOE6 strengths · Avg: 9.2/10
Operating MarginProfitability
34.6%10/10

Strong operational efficiency at 34.6%

EPS GrowthGrowth
50.2%10/10

Earnings expanding 50.2% YoY

Return on EquityProfitability
24.1%9/10

Every $100 of equity generates 24 in profit

Profit MarginProfitability
26.7%9/10

Keeps 27 of every $100 in revenue as profit

Debt/EquityHealth
0.289/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
22.9%8/10

Revenue surging 22.9% year-over-year

CME4 strengths · Avg: 9.5/10
Profit MarginProfitability
63.4%10/10

Keeps 63 of every $100 in revenue as profit

Operating MarginProfitability
65.0%10/10

Strong operational efficiency at 65.0%

Market CapQuality
$99.08B9/10

Large-cap with strong market position

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

Areas to Watch

CBOE2 concerns · Avg: 2.0/10
PEG RatioValuation
2.642/10

Expensive relative to growth rate

Free Cash FlowQuality
$-536.30M2/10

Negative free cash flow — burning cash

CME4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.8%4/10

0.8% revenue growth

EPS GrowthGrowth
2.5%4/10

2.5% earnings growth

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

PEG RatioValuation
4.782/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : CBOE

The strongest argument for CBOE centers on Operating Margin, EPS Growth, Return on Equity. Profitability is solid with margins at 26.7% and operating margin at 34.6%. Revenue growth of 22.9% demonstrates continued momentum.

Bull Case : CME

The strongest argument for CME centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 63.4% and operating margin at 65.0%.

Bear Case : CBOE

The primary concerns for CBOE are PEG Ratio, Free Cash Flow.

Bear Case : CME

The primary concerns for CME are Revenue Growth, EPS Growth, Piotroski F-Score.

Key Dynamics to Monitor

CBOE profiles as a growth stock while CME is a value play — different risk/reward profiles.

CBOE carries more volatility with a beta of 0.41 — expect wider price swings.

CBOE is growing revenue faster at 22.9% — sustainability is the question.

CME generates stronger free cash flow (924M), providing more financial flexibility.

Bottom Line

CBOE scores higher overall (74/100 vs 55/100), backed by strong 26.7% margins and 22.9% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cboe Global Markets Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

Cboe Global Markets is an American company that owns the Chicago Board Options Exchange and the stock exchange operator BATS Global Markets.

Visit Website →

CME Group Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

CME Group Inc. (Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, The Commodity Exchange) is an American global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, stock indexes and cryptocurrencies futures.

Visit Website →

Want to dig deeper into these stocks?